Home Cart 0 Sign in  

[ CAS No. 65271-80-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 65271-80-9
Chemical Structure| 65271-80-9
Structure of 65271-80-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 65271-80-9 ]

Related Doc. of [ 65271-80-9 ]

Alternatived Products of [ 65271-80-9 ]

Product Details of [ 65271-80-9 ]

CAS No. :65271-80-9 MDL No. :
Formula : C22H28N4O6 Boiling Point : -
Linear Structure Formula :- InChI Key :KKZJGLLVHKMTCM-UHFFFAOYSA-N
M.W : 444.48 Pubchem ID :4212
Synonyms :
Mitozantrone;NSC 301739

Calculated chemistry of [ 65271-80-9 ]

Physicochemical Properties

Num. heavy atoms : 32
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.36
Num. rotatable bonds : 12
Num. H-bond acceptors : 8.0
Num. H-bond donors : 8.0
Molar Refractivity : 119.18
TPSA : 163.18 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.3 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.03
Log Po/w (XLOGP3) : 1.0
Log Po/w (WLOGP) : -0.52
Log Po/w (MLOGP) : -1.69
Log Po/w (SILICOS-IT) : 1.62
Consensus Log Po/w : 0.69

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 2.0
Egan : 1.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.71
Solubility : 0.864 mg/ml ; 0.00194 mol/l
Class : Soluble
Log S (Ali) : -4.02
Solubility : 0.0429 mg/ml ; 0.0000965 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -6.27
Solubility : 0.000239 mg/ml ; 0.000000537 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 2.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.61

Safety of [ 65271-80-9 ]

Signal Word:Danger Class:9
Precautionary Statements:P201-P273-P308+P313 UN#:3077
Hazard Statements:H350-H410 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 65271-80-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 65271-80-9 ]
  • Downstream synthetic route of [ 65271-80-9 ]

[ 65271-80-9 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 81-59-4 ]
  • [ 111-41-1 ]
  • [ 65271-80-9 ]
YieldReaction ConditionsOperation in experiment
38% at 53℃; for 2.2 h; Inert atmosphere 1 at room temperature, add 10.5g of 1,4,5,8-tetrahydroxyindole leuco in a 250ml three-necked flask, and then evacuate the air in a 250ml three-necked flask with a balloon containing nitrogen or argon;2 After venting the air in a 250 ml three-necked flask, add 59 ml of 1,4 dioxane and start stirring.Until the 1,4,5,8-tetrahydroxyindole leuco is completely dissolved in the 1,4-dioxane;3 After completion of the above 2, 38 g of N-(2-hydroxyethyl)ethylenediamine was added to a constant pressure titration funnel, and then N-(2-hydroxyethyl)ethylenediamine was added dropwise to a 250 ml three-necked flask. Continuous stirring during the dropping process, the dropping time is 14 minutes, and after the end of the dropwise addition, a paste-like viscous liquid is obtained;4 After completing the above 3, a 250 ml three-necked flask containing a paste-like viscous liquid is heated in a water bath, the temperature is controlled at 53 ° C, and the reaction is carried out at this temperature for 2.2 hours. After the reaction, a blue-brown or blue-violet color is obtained. Oily liquid, product D;5 Pour the obtained product D into a stoppered jar, add 170 ml of absolute ethanol, record the liquid scale at this time, and then put the stoppered jar into the water bath to control the heat temperature to 59 °C. And continuously pass dry oxygen dried with anhydrous calcium sulfate into the stoppered jar, and slowly oxidize for 5.5 hours at a temperature of 59 ° C until the color of the reaction liquid changes to bright blue;6 Let the bright blue liquid obtained be cooled to room temperature, and add the remaining amount of ethanol in a stoppered jar until the liquid scale recorded in the above 5 is allowed to stand at room temperature for 30 hours, then the bright blue liquid is poured. Into a Buchner funnel for vacuum filtration to obtain a blue drug substance crystal, that is, product E;Step 2: Refinement of APIs:1 in the beaker, according to the ratio of absolute ethanol to n-hexane volume ratio of 3:1 ratio of 180ml;2 Weigh 9g of product E, pour it into a three-necked bottle, then pour the mixture of the above 1 into a three-necked bottle, and put the three-necked bottle into a water bath to stir and dissolve. The dissolution temperature was controlled to 54 ° C. After complete dissolution, the activated carbon was added to the stoppered three-necked flask, and the mixture was continuously stirred and heated to reflux. The temperature of the hot reflux was controlled to 68 ° C.The control was carried out for 22 minutes. Immediately after the completion of the hot reflux, the filtrate was filtered under reduced pressure to obtain a filtrate. The obtained filtrate was allowed to cool, and crystals were precipitated by ice-cooling overnight, and then subjected to vacuum filtration to obtain a crystal of the drug;3 Configure the mixture in the above 1 again, and then rinse the obtained drug crystals several times until there is no visible reddish-brown blue crystal in the product, which has a clear luster and is evenly granulated. After the rinsing is finished, The crystal is dried in a constant temperature drying oven, the drying temperature is 105 ° C, the drying time is 1.9 hours, and after the drying is finished, it is refined.The medicine, namely mitoxantrone hydrochloride.The content of the obtained mitoxantrone hydrochloride drug was measured by HPLC-UV, and the yield was 38percent.
Reference: [1] Patent: CN108395379, 2018, A, . Location in patent: Paragraph 0023; 0025-0077
  • 2
  • [ 70476-74-3 ]
  • [ 65271-80-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1979, vol. 22, # 9, p. 1024 - 1030
  • 3
  • [ 81-59-4 ]
  • [ 65271-80-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1979, vol. 22, # 9, p. 1024 - 1030
  • 4
  • [ 131401-54-2 ]
  • [ 111-41-1 ]
  • [ 65271-80-9 ]
  • [ 134529-38-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 8, p. 2373 - 2380
  • 5
  • [ 131401-54-2 ]
  • [ 111-41-1 ]
  • [ 65271-80-9 ]
Reference: [1] ChemMedChem, 2015, vol. 10, # 9, p. 1528 - 1538
Same Skeleton Products
Historical Records

Similar Product of
[ 65271-80-9 ]

Chemical Structure| 70711-41-0

A1627333[ 70711-41-0 ]

1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthracene-9,10-dione diacetate

Reason: Free-salt